Flow cytometric evaluation is also widely used in the early diagnosis of MSMD, especially in patients deficient in surface expression of biomarkers such as IFNGR1, IFNGR2, IL-12RB1 and IL-12RB2. This evidence concerns the gene IFNGR2 and Mendelian susceptibility to mycobacterial diseases.